Y.b Urban Renewal - Residential Development Ltd. · TASE:YBRD

Y.b Urban Renewal - Residential Development — Cannassure Therapeutics — Investor Presentation (May 2020)

24 slides from Y.b Urban Renewal - Residential Development's investor presentation, May 2020

  1. Slide 1: Cannassure: Delivering Value, Ensuring Quality

    ose cannassure Delivering Value Ensurinc Quality

  2. Slide 2: Forward Looking Statements

    Forward Looking This presentation has been prepared by the Company and should not be considered as a recommendation that characterize the company’s operations, as well as from developments in the competitive and business Statements or recommendation for the purchase or sale of securities and / or in

  3. Slide 3: An Exceptional Opportunity

    An Exceptional Opportunity Medicinal cannabis market is poised for exponential growth Medical cannabis products are widely recognized as effective Demand is growing for medical cannabis treatments $20.2B $22.3B $20.1B USA EUROPE Market is opening up and more countries authorize the use and trade of

  4. Slide 4: The Next Sure Thing

    The Next Sure Thing Cannassure is capitalizing on this Targeting 3 Growth Engines exceptional opportunity and is ready • Medical cannabis flowers & extracts to go to market • Drug-device combination products Israel – commercial launch in early 2020 based on established devices Market growing rapidly

  5. Slide 5: Unique Value Proposition

    Unique Value Proposition Developing and commercializing proprietary novel medical cannabis products Competitive Edge Cannassure’s unique strategy combines control of the entire medical cannabis value chain together with innovative drug delivery combination products which address clear unmet needs in

  6. Slide 6: Proven Experience & Knowhow

    Proven Experience & Knowhow Built on a Firm Foundation Groundbreaking R&D Founded by Solbar, a leading botanical Led by experienced and successful team in extraction specialist with 60 years of experience developing cutting-edge pharmaceutical and track record as a trusted supplier to leading produc

  7. Slide 7: Led by a Strong Team

    Led by a Strong Team Major General Ido Nehushtan Ran Amir Chairman of the Board CEO and BOD member Former commander of the Israel Air Force, Ido Ran has more than 15 years of extensive has extensive managerial experience from his international experience in operations and years in the Air Force, IDF

  8. Slide 8: Led by a Strong Team

    Led by a Strong Team Hadar Cohen Dana Marom Production Manager Chief Quality Manager With 20 years of manufacturing experience in With 15 years of extensive international the pharmaceutical industry, including experience in Quality Management & R&D, NASDAQ:KMDA. Hadar is well versed in FDA Dana has

  9. Slide 9: Backed by an Accomplished Scientific Advisory Board

    Backed by an Accomplished Scientific Advisory Board Prof. Tamar Peretz Dr. Shimon Amselem Dr. Yafit Stark Prof. Peretz, MD, serves at Head of Dr. Amselem is a pharmaceutical and Dr. Stark established and managed the Sharett Institute of Oncology of biotech consultant with expertise in Global Clinica

  10. Slide 10: Indoor Cultivation, Extraction & Processing Approach

    Indoor Cultivation Extraction & Processing Approach Marketing & Supply Chain Product Development

  11. Slide 11: Indoor Aeroponic Cultivation Ensures Consistency, Quality, and High Yield

    Indoor Aeroponic Cultivation Ensures Consistency, Quality, and High Yield

  12. Slide 12: Addressing Pharmaceutical Grade Standards

    Addressing Pharmaceutical Grade Standards Meets official standards and customer expectations of quality, safety, consistency and reliability 12

  13. Slide 13: Optimal Growing Conditions

    Optimal Growing Conditions Indoor aeroponics provides perfect environmental conditions Fast & efficient cultivation with 6 annual growing cycles Cannassure is one of the few growers worldwide using aeroponic technology 13

  14. Slide 14: Key Reliability & Safety Features

    Key Reliability & Safety Features Fully controlled Reduce the need for No damage from No impurities from environment herbicides and pesticides weather conditions pests or outdoor debris Water Continuous monitoring Minimal human touch efficient of fertilizer and humidity no contamination 14

  15. Slide 15: State-of-the-Art Extraction & Processing

    State-of-the-Art Extraction & Processing

  16. Slide 16: Years of experience go into every product

    years of experience go into Exceptionally high every product quality products Modern processing and extraction QA/QP lab utilizes comprehensive facility complies with medical grade analytical methods to ensure the standards development of consistent, reliable, safe and effective treatments 16

  17. Slide 17: Built-In Quality Culture in Every Stage of the Value Chain

    Built-In Quality Culture in Every Stage of the Value Chain

  18. Slide 18: A Culture of Quality

    A Culture of Quality Strong Heritage Experienced Team National Support Quality is part of the company’s Cannassure’s team has a Cannassure’s validated analytical DNA, built on Solbar’s strong distinguished track record in QA methods were acknowledged by track record as a trusted supplier and develop

  19. Slide 19: Innovative Product Portfolio for Today & Tomorrow

    Innovative Product Portfolio for Today & Tomorrow

  20. Slide 20: Growth Engines

    Growth Engines Commercial Under development medical cannabis Superior quality medical cannabis Proprietary innovative topical & Products based on specific flowers & oil extracts oral products cannabinoids 20

  21. Slide 21: High Quality Medical Cannabis Flowers and Oil Extracts

    High Quality Medical Cannabis Flowers and Oil Extracts Commercial Under development Medical cannabis Ready for Market Commercial launch of 1st products in early 2020 to Israel’s rapidly growing market Established supply chain & distribution network Agreements signed with leading pharmacies and medic

  22. Slide 22: Innovative Medical Cannabis Products

    Innovative Medical Cannabis Products Proprietary innovative medical products based on established delivery devices & technologies Commercial Under development Medical cannabis Development of unique formulations for enhanced therapeutic value Commenced co-development with Lipidor AB (Nasdaq First Nor

  23. Slide 23: Products based on Specific Cannabinoids

    Products based on Specific Cannabinoids Commercial Under development Medical cannabis Innovative targeted & slow-release platform for unmet female health needs Proprietary patent applications filed for pure cannabinoid-based intrauterine device (IUD) targeting the rising women's health market 23

  24. Slide 24: The future is cannabis

    The future is cannabis The breakthrough 's Cannassure - —_— 7 —<—

Cannassure Therapeutics — Investor Presentation (May 2020) on 6ix